Disease Progression in Idiopathic Pulmonary Fibrosis FVC Is Not Enough

被引：7
|
作者：
Behr, Juergen [1 ,2 ]
机构：
[1] Klinikum LMU, Munich, Germany
[2] German Ctr Lung Res, Asklepios Fachkliniken Munchen Gauting, Munich, Germany
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2017年 / 196卷 / 09期
关键词：
LUNG-FUNCTION; EMPHYSEMA; SURVIVAL; PHYSIOLOGY;
D O I：
10.1164/rccm.201706-1246ED
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：1094 / 1095
页数：2
相关论文
共 50 条
  • [1] Predictive biomarkers of disease progression in idiopathic pulmonary fibrosis
    Zhu, Weiwei
    Liu, Chunquan
    Tan, Chunting
    Zhang, Jie
    HELIYON, 2024, 10 (01)
  • [2] Nitrogen dioxide increases the risk of disease progression in idiopathic pulmonary fibrosis
    Yoon, Hee-Young
    Kim, Sun-Young
    Kim, Ok-Jin
    Song, Jin Woo
    RESPIROLOGY, 2023, 28 (03) : 254 - 261
  • [3] Disease progression in idiopathic pulmonary fibrosis without pulmonary function impairment
    Kondoh, Yasuhiro
    Taniguchi, Hiroyuki
    Ogura, Takashi
    Johkoh, Takeshi
    Fujimoto, Kiminori
    Sumikawa, Hiromitsu
    Kataoka, Kensuke
    Baba, Tomohisa
    Colby, Thomas V.
    Kitaichi, Masanori
    RESPIROLOGY, 2013, 18 (05) : 820 - 826
  • [4] Periostin promotes fibrosis and predicts progression in patients with idiopathic pulmonary fibrosis
    Naik, Payal K.
    Bozyk, Paul D.
    Bentley, J. Kelley
    Popova, Antonia P.
    Birch, Carolyn M.
    Wilke, Carol A.
    Fry, Christopher D.
    White, Eric S.
    Sisson, Thomas H.
    Tayob, Nabihah
    Carnemolla, Barbara
    Orecchia, Paola
    Flaherty, Kevin R.
    Hershenson, Marc B.
    Murray, Susan
    Martinez, Fernando J.
    Moore, Bethany B.
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2012, 303 (12) : L1046 - L1056
  • [5] Mediastinal lymph node enlargement in idiopathic pulmonary fibrosis: relationships with disease progression and pulmonary function trends
    Sgalla, Giacomo
    Larici, Anna Rita
    Golfi, Nicoletta
    Calvello, Mariarosaria
    Farchione, Alessandra
    Del Ciello, Annemilia
    Varone, Francesco
    Iovene, Bruno
    Manfredi, Riccardo
    Richeldi, Luca
    BMC PULMONARY MEDICINE, 2020, 20 (01)
  • [6] Predictors of Mortality Poorly Predict Common Measures of Disease Progression in Idiopathic Pulmonary Fibrosis
    Ley, Brett
    Bradford, Williamson Z.
    Vittinghoff, Eric
    Weycker, Derek
    du Bois, Roland M.
    Collard, Harold R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 194 (06) : 711 - 718
  • [7] DISEASE PROGRESSION IN IDIOPATHIC PULMONARY FIBROSIS UNDER ANTI-FIBROTIC TREATMENT
    Cilli, Aykut
    Uzer, Fatih
    SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, 2023, 40 (03)
  • [8] Disease progression in idiopathic pulmonary fibrosis with mild physiological impairment: analysis from the Australian IPF registry
    Jo, Helen E.
    Glaspole, Ian
    Moodley, Yuben
    Chapman, Sally
    Ellis, Samantha
    Goh, Nicole
    Hopkins, Peter
    Keir, Greg
    Mahar, Annabelle
    Cooper, Wendy
    Reynolds, Paul
    Walters, E. Haydn
    Zappala, Christopher
    Grainge, Christopher
    Allan, Heather
    Macansh, Sacha
    Corte, Tamera J.
    BMC PULMONARY MEDICINE, 2018, 18
  • [9] Sensitivity Analyses of the Change in FVC in a Phase 3 Trial of Pirfenidone for Idiopathic Pulmonary Fibrosis
    Lederer, David J.
    Bradford, Williamson Z.
    Fagan, Elizabeth A.
    Glaspole, Ian
    Glassberg, Marilyn K.
    Glasscock, Kenneth F.
    Kardatzke, David
    King, Talmadge E., Jr.
    Lancaster, Lisa H.
    Nathan, Steven D.
    Pereira, Carlos A.
    Sahn, Steven A.
    Swigris, Jeffrey J.
    Noble, Paul W.
    CHEST, 2015, 148 (01) : 196 - 201
  • [10] Modification of the course of disease progression in idiopathic pulmonary fibrosis by pirfenidone: evidence of the potential for disease reversal
    Herrmann, Alexander
    Parr, David
    BMJ CASE REPORTS, 2025, 18 (03)
12345